Abound Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Abound Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15K	Hold	56	–	–	﹤0.01%	799
2026 Q1	$891	Hold	56	–	–	﹤0.01%	992
2025 Q4	$1.47K	Hold	56	–	–	﹤0.01%	882
2025 Q3	$1.27K	Hold	56	–	–	﹤0.01%	851
2025 Q2	$1.11K	Hold	56	–	–	﹤0.01%	794
2025 Q1	$947	Sell	56 -8	-13%	-$136	﹤0.01%	765
2024 Q4	$1.18K	Hold	64	–	–	﹤0.01%	720
2024 Q3	$1.39K	Buy	64 +8	+14%	+$179	﹤0.01%	744
2024 Q2	$1.1K	Hold	56	–	–	﹤0.01%	714
2024 Q1	$1.22K	Hold	56	–	–	﹤0.01%	750
2023 Q4	$1.62K	Hold	56	–	–	﹤0.01%	683
2023 Q3	$1.5K	Hold	56	–	–	﹤0.01%	660
2023 Q2	$2.07K	Hold	56	–	–	﹤0.01%	642
2023 Q1	$1.75K	Hold	56	–	–	﹤0.01%	598
2022 Q4	$1.67K	Hold	56	–	–	﹤0.01%	560
2022 Q3	$2.13K	Buy	+56	New	+$2.81K	﹤0.01%	469

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Abound Wealth Management's FLGT Position: Q2 2026 in Review

Abound Wealth Management held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 56 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Abound Wealth Management first reported a position in FLGT in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.13K in Q3 2022. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

Abound Wealth Management held 56 shares of Fulgent Genetics worth $1.15K as of Q2 2026.
Abound Wealth Management left its Fulgent Genetics share count unchanged in Q2 2026.
Fulgent Genetics made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #799 holding.
Abound Wealth Management first reported a position in Fulgent Genetics in Q3 2022 and has held it in 16 quarters since.
Abound Wealth Management's Fulgent Genetics position peaked at $2.13K in Q3 2022.
142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.